免疫血凝实验在癌症患者手术前后红细胞免疫功能评价中的应用

Application of immune hemagglutination test in evaluation of preoperative and postoperative erythrocyte immune status in patients carcinoma

目的探讨免疫血凝实验在检测癌症患者红细胞免疫功能方面的临床应用。方法采用免疫血凝实验检测23例癌症患者(癌症组)红细胞免疫功能,并与30例健康献血员(正常对照组)进行比较。结果癌症患者免疫血凝实验阳性率均低于正常对照组,患者术后红细胞免疫功能呈现暂时性抑制到逐渐恢复的过程。结论切除癌症病灶可对患者红细胞免疫功能起恢复作用;免疫血凝实验检测机体红细胞免疫功能,方法简便易行,其结果可作为癌症患者病情监测及预后判断的重要参考指标。

Objective To investigating erythrocytes in the patients with carcinoma. Methods The immune function of red blood cell from 23 patients with carcinoma were detected by the immune hemagglutination test,and 30 cases of healthy blood donors were enrolled as normal control. Results Positive rate of immune hemagglutination test in the patients with carcinoma were lower than that of the normal control. Postoperative immune function of red blood cell would present the process from the temporary inhibition to the gradual recovery. Conclusion The data suggest that a complete tumor removal would play a role in the restoration of the patient＇s red cell immune status. This method of immune hemagglutination test was easier than the others. The results could provide important referential value for monitoring patien（s condition and postoperative prognosis.